Approved Products
Through partnerships with the world's leading biopharmaceutical companies, Nektar has enabled highly successful products in a number of therapeutic areas that are used by medical professionals and patients across the globe.
| Cimzia® |
Approved in U.S. |
Crohn's disease |
 |
Immunology |
| MIRCERA® |
Approved in EU/U.S. |
Anemia in chronic kidney disease (CKD) |
 |
Nephrology |
| Neulasta® |
Approved |
Neutropenia |
 |
Oncology |
| PEGASYS® |
Approved |
Hepatitis C |
|
Immunology |
| PEG-INTRON® |
Approved |
Hepatitis C |
 |
Immunology |
| DEFINITY® Vial |
Approved |
Diagnostic |
 |
Surgical/Imaging |
| DuraSeal® |
Approved |
Cranial Durant Sealant |
 |
Surgical/Imaging |
| Somavert® |
Approved |
Acromegaly |
 |
Immunology |
| Macugen® |
Approved |
Wet age-related macular degeneration |
 |
Ocular |
 |
Return to top »
* Cimzia® is a registered trademark of UCB; MIRCERA is a registered trademark of Roche; Neulasta is a registered trademark of Amgen; PEGASYS is a registered trademark of Roche; PEG-INTRON is a registered trademark of Schering-Plough; DEFINITY is a registered trademark of Bristol-Myers Squibb; DuraSeal is a registered trademark of Confluent Surgical; Somavert is a registered trademark of Pfizer; Macugen is a registered trademark of OSI Pharmaceuticals.
|
